Evidence map›Paper›PMID 31680967›Full record

ArticleFrontiers in pharmacology2019

Chinese Herbal Formula (CHF03) Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) Through Inhibiting Lipogenesis and Anti-Oxidation Mechanisms.

Yizhe Cui, Renxu Chang, Tao Zhang, Xiaocui Zhou, Qiuju Wang, Haiyun Gao, Lintong Hou, Juan J Loor, Chuang Xu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Effect of L-carnitine on regeneration in experimental partial hepatectomy model in rats.Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Network Pharmacology-Based Analysis ofFrontiers in pharmacology · 2021
    Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Yizhe CuiCollege of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, China.
Renxu ChangCollege of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, China.
Tao ZhangOpen Project Program of Beijing Key Laboratory of Traditional Chinese Veterinary Medicine, Beijing University of Agriculture, Beijing, China.
Xiaocui ZhouLaboratory of Zoonosis, China Animal Health and Epidemiology Center, Qingdao, China.
Qiuju WangCollege of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, China.
Haiyun GaoCollege of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, China.
Lintong HouCollege of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, China.
Juan J LoorDepartment of Animal Sciences and Division of Nutritional Sciences, University of Illinois, Urbana, IL, United States.
Chuang XuCollege of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, China.
Heilongjiang Bayi Agricultural University · CNBeijing University of Agriculture · CNChina Animal Health and Epidemiology Center · CNUniversity of Illinois Urbana-Champaign · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a hepatic ailment with a rapidly increasing incidence in the human population due largely to dietary hyper nutrition and subsequent obesity. Discovering effective natural compounds and herbs against NAFLD can provide alternative and complementary medical treatments to current chemical pharmaceuticals. In this study, ICR male mice were fed a high-fat diet (HFD)

Indexed as

hepatocytesherbal formulahigh-fat dietNF-κBnonalcoholic fatty liver disease

Identifiers

PMID31680967
PMCPMC6803500
OpenAlexW2981228619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.